Daniel Liebowitz

Daniel Liebowitz

Auto-generated profile, based on publicly available information

Daniel Liebowitz

Department of Internal Medicine, University of Maryland Medical Center, Baltimore, MD, USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2011 in Dalton Transactions
Verified
Journal Article
Closed access
PDF file
BDBruno Demoro
Bruno Demoro
CSCynthia Sarniguet
Cynthia Sarniguet
RSRoberto Sánchez-Delgado
Roberto Sánchez-Delgado
Miriam RossiMiriam Rossi
Miriam Rossi
DLDaniel Liebowitz
Daniel Liebowitz
Dinorah GambinoDinorah Gambino
Dinorah Gambino
In the search for new therapeutic tools against neglected diseases produced by trypanosomatid parasites, and particularly against African Trypanosomiasis, whose etiological agent is Trypanosoma brucei, organoruthenium compounds with bioactive nitrofuran containing thiosemicarbazones (L) as co-ligands were obtained. Four ruthenium(II) complexes with the formula [Ru2(p-cymene)2(L)2]X2 , where X = Cl or PF6 , were synthesized and the crystal structures of two of them were solved by X-ray diffraction methods. Two of the complexes show significant in vitro growth inhibition activity against Trypanosoma brucei brucei and are highly selective towards trypanosomal cells with respect to mammalian cells (J774 murine macrophages). These promising results make the title organoruthenium compounds good lead candidates for further developments towards potential antitrypanosomal organometallic drugs.

7 April 2013 in Biological Trace Element Research
Verified
Journal Article
Closed access
PDF file
BDBruno Demoro
Bruno Demoro
Miriam RossiMiriam Rossi
Miriam Rossi
FCFrancesco Caruso
Francesco Caruso
DLDaniel Liebowitz
Daniel Liebowitz
COClaudio Olea-Azar
Claudio Olea-Azar
Dinorah GambinoDinorah Gambino
Dinorah Gambino

22 March 2016 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
SBShaibal Banerjee
Shaibal Banerjee
SSSaikat Sinha
Saikat Sinha
PPPadmanava Pradhan
Padmanava Pradhan
ACAlessio Caruso
Alessio Caruso
DLDaniel Liebowitz
Daniel Liebowitz
BZBarbara Zajc
Barbara Zajc

2 January 2017 in Journal of Community Hospital Internal Medicine Perspectives
Verified
Journal Article
Open access
DLDan Liebowitz
Dan Liebowitz
Smallpox was eradicated by the World Health Organization in 1980. Before its eradication thedisease had a mortality rate upwards of 50% and had a significant impact on society. During theAmerican Revolutionary war, smallpox outbreaks were impeding the American war effort until1777 when George Washington carried out a mass inoculation campaign in the ContinentalArmy that reduced the mortality from smallpox to less than 2%. Inoculation was an early formof vaccination that used live virus from active pustules to induce a milder, but still sometimesdeadly, case of disease. Washington has been credited with helping to ease the burden ofsmallpox on the Army which improved the odds of success against the British. When EdwardJenner’s vaccine reached America it was more readily accepted by political and medical leadersdue the success of Washington’s inoculation campaign. The Founding Fathers argued thatsmallpox vaccination was the greatest discovery in modern medicine and they were likely correctthat it helped to usher in the modern era of vaccinology.